Riham A. Shiekh-El

Kasr El Aini St
Cairo, C 11562, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Phytochemical profiling of Olea europaea subsp. cuspidata aerial parts using LC-DAD-QToF: cholinesterase inhibition and molecular docking insights into potential Alzheimer's disease targets.

Phytochemical profiling of Olea europaea subsp. cuspidata aerial parts using LC-DAD-QToF: cholinesterase inhibition and molecular docking insights into potential Alzheimer's disease targets.

Journal: Natural product research

Published: September 02, 2026

Design, Synthesis, X-Ray Crystallographic Characterization, Anticholinesterase and Antioxidant Evaluation, and Molecular Modeling of Novel Dispiroindene-Pyrrolidine Derivatives as Multifunctional Anti-Alzheimer Agents.

Design, Synthesis, X-Ray Crystallographic Characterization, Anticholinesterase and Antioxidant Evaluation, and Molecular Modeling of Novel Dispiroindene-Pyrrolidine Derivatives as Multifunctional Anti-Alzheimer Agents.

Journal: Drug development research

Published: June 05, 2026

Transforming surgical decisions: the rise of predictive and personalized digital tools.

Transforming surgical decisions: the rise of predictive and personalized digital tools.

Journal: Expert review of medical devices

Published: May 27, 2026

Transforming surgical decisions: the rise of predictive and personalized digital tools.

Transforming surgical decisions: the rise of predictive and personalized digital tools.

Journal: Expert review of medical devices

Published: May 27, 2026

Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells.

Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells.

Journal: Bioorganic chemistry

Published: May 21, 2026

Neurogenesis and neuroplasticity activities of natural products: therapeutic potential in Alzheimer's disease.

Neurogenesis and neuroplasticity activities of natural products: therapeutic potential in Alzheimer's disease.

Journal: Frontiers in pharmacology

Published: April 23, 2026

Evaluation of Desmidorchis adenensis for Wound-Healing: Targeting Inflammation, Redox Balance, and FOXO1/MIP-2 Signaling in a Murine Model.

Evaluation of Desmidorchis adenensis for Wound-Healing: Targeting Inflammation, Redox Balance, and FOXO1/MIP-2 Signaling in a Murine Model.

Journal: Journal of ethnopharmacology

Published: April 14, 2026

Aucubin as a multifunctional iridoid glycoside: Molecular pharmacology and therapeutic mechanisms supporting its potential as a drug discovery scaffold.

Aucubin as a multifunctional iridoid glycoside: Molecular pharmacology and therapeutic mechanisms supporting its potential as a drug discovery scaffold.

Journal: European journal of pharmacology

Published: March 26, 2026

A comprehensive review of ischemic heart disease: pathophysiology, current treatments, natural products-based therapies, and nanotherapeutics.

A comprehensive review of ischemic heart disease: pathophysiology, current treatments, natural products-based therapies, and nanotherapeutics.

Journal: Frontiers in pharmacology

Published: March 19, 2026

Discovery of Caralluma-derived pregnane glycosides as potent and selective cholinesterase inhibitors: integrated in silico and in vitro evaluation.

Discovery of Caralluma-derived pregnane glycosides as potent and selective cholinesterase inhibitors: integrated in silico and in vitro evaluation.

Journal: RSC advances

Published: February 21, 2026

Exploring the therapeutic potential of Lupeol isolated from Ochrosia elliptica Labill. leaves in polycystic ovarian syndrome.

Exploring the therapeutic potential of Lupeol isolated from Ochrosia elliptica Labill. leaves in polycystic ovarian syndrome.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 18, 2026

Signaling pathways driving multiple sclerosis: From mechanisms to natural‑product interventions.

Signaling pathways driving multiple sclerosis: From mechanisms to natural‑product interventions.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 14, 2026

Showing 1-12 of 106

Last Updated: 09/26/2026